脱氢吲达帕胺
|
|
|
- CAS号:
- 63968-75-2
- 英文名:
- INDAPAMIDE RELATED COMPOUND A (50 MG) (4-CHLORO-N-(2-METHYL-INDOL-1-YL)-3-SULFAMOYLBEN-ZAMIDE) (AS)
- 英文别名:
- Dehydro Indapamide;Indapamide Impurity 4;Indapamide impurity II;Indapamide EP Impurity B;Indapamide impurity B CRS;Indapamide impurity B (EP);IndapaMide Related CoMpound A;Indapamide USP Related Compound A;4-Chloro-N-(2-methyl-1H-indol-1-yl);Indapamide Impurity 2（EP Impurity B）
- 中文名:
- 脱氢吲达帕胺
- 中文别名:
- 脱氢吲达帕胺;去氢吲达帕胺;吲达帕胺杂质II;吲达帕胺杂质02;吲达帕胺相关物质A;吲达帕胺EP杂质B;吲达帕胺杂质B 标准品;吲达帕胺杂质B(EP);吲达帕胺杂质B EP标准品;吲达帕胺相关化合物A(USP)
- CBNumber:
- CB5500525
- 分子式:
- C16H14ClN3O3S
- 分子量:
- 363.82
- MOL File:
- 63968-75-2.mol
|
|
|
脱氢吲达帕胺化学性质
-
熔点:
-
255-257℃
-
|
-
密度:
-
1.49±0.1 g/cm3(Predicted)
-
|
-
储存条件:
-
Refrigerator
-
|
-
溶解度:
-
DMSO (Slightly), Methanol (Slightly, Heated)
-
|
-
酸度系数(pKa):
-
9.36±0.60(Predicted)
-
|
-
颜色:
-
White to Light Brown
-
|
脱氢吲达帕胺性质、用途与生产工艺
脱氢吲达帕胺是一种属于抗高血压药的药物。 它是一种前体药物，在体内代谢为吲达帕胺和氢氯噻嗪。 脱氢吲达帕胺已被证明可有效治疗高血压，其药代动力学特征与其他利尿剂相似。
脱氢吲达帕胺
上下游产品信息
上游原料
下游产品
63968-75-2, 脱氢吲达帕胺 相关搜索:
- Sulfur & Selenium Compounds
- Pharmaceuticals
- Metabolites & Impurities
- Isotope Labelled Compounds
- Intermediates & Fine Chemicals
- Indole Derivatives
- Heterocycles
- 高端化学
- 295-吲达帕胺
- 吲达帕胺杂质
- 杂质对照品
- 对照品-杂质对照品
- 吲达帕胺杂质B 4-氯-N-(2-甲基-1-氢-吲哚基)-3-磺酰胺基苯甲酰胺
- 吲达帕胺杂质2(吲达帕胺EP杂质B)
- 吲达帕胺杂质02
- 4-氯-N-(2-甲基-1H-吲哚-1-基)-3-氨磺酰基苯甲酰胺
- 吲达帕胺杂质II
- 4-氯-N-(2-甲基-1-吲哚基)-3-氨基磺酰基苯甲酰胺
- 吲达帕胺相关物质A USP标准品
- INDAPAMIDE EP杂质 B[干冰运输]
- 吲达帕胺杂质B EP标准品
- 吲达帕胺杂质B 标准品
- 吲达帕胺相关化合物A(USP)
- 吲达帕胺杂质B(EP)
- 吲达帕胺EP杂质B
- 吲达帕胺EP杂质B(脱氢吲达帕胺)
- 4-氯-N-(2-甲基-1H-吲哚-1-基)-3-氨磺酰基苯酰胺
- 脱氢吲达帕胺
- 去氢吲达帕胺
- 吲达帕胺相关物质A
- 63968-75-2
- Indapamide USP Related Compound A
- Indapamide Related Compound A (4-chloro-N-(2-methyl-1H-indol-1-yl)-3-sulfamoylbenzamide) (1338812)
- Indapamide EP Impurity BQ: What is
Indapamide EP Impurity B Q: What is the CAS Number of
Indapamide EP Impurity B Q: What is the storage condition of
Indapamide EP Impurity B Q: What are the applications of
Indapamide EP Impurity B
- Indapamide impurity II
- 4-chloro-N-(2-methyl-1H-indol-1-yl)-3-sulfamoylbenzamide
- Indapamide Impurity 2（EP Impurity B）
- Benzamide, 3-(aminosulfonyl)-4-chloro-N-(2-methyl-1H-indol-1-yl)-
- Indapamide impurity B CRS
- 4-Chloro-N-(2-methyl-1H-indol-1-yl)
- Indapamide Impurity 2(Indapamide EP Impurity B)
- Indapamide EP Impurity B
- 4-chloro-N-(2-methylindol-1-yl)-3-sulfamoylbenzamide
- Indapamide impurity B (EP)
- Indapamide Impurity 4
- Indapamide EP Impurity B (Dehydro Indapamide)
- IndapaMide Related CoMpound A
- Indapamide Related Compound A (50 mg) (4-chloro-N-(2-methyl-1H-indol-1-yl)-3-sulfamoylbenzamide)
- 4-Chloro-N-(2-methyl-1H-indol-1-yl]-3-sulphamoylbenzamide
- 4-Chloro-3-sulfaMoyl-N-(2-Methyl-1H-indol-1-yl)benzaMide
- 3-(AMinosulfonyl)-4-chloro-N-(2-Methyl-1H-indol-1-yl)benzaMide
- Dehydro Indapamide
- 4-chloro-n-(2-methyl-1-indolyl)-3-sulfamoylbenzamide
- 4-chloro-n-(2-methyl-1-indolyl)-3-sulfamoyl-benzamid
- 3-(aminosulfonyl)-4-chloro-n-(2-methyl-1h-indol-1-yl)-benzamid
- INDAPAMIDE RELATED COMPOUND A (50 MG) (4-CHLORO-N-(2-METHYL-INDOL-1-YL)-3-SULFAMOYLBEN-ZAMIDE) (AS)